Literature DB >> 8447399

Regulation of intestinal epithelial proliferation: a few answers, many questions.

D K Podolsky1.   

Abstract

The epithelium of the gastrointestinal tract mucosa is a highly dynamic and diverse mixture of cell populations requiring exquisite integration of the processes of cellular proliferation, differentiation, and senescence. It is likely that the proliferative compartment of the intestinal epithelium encompasses a hierarchy of totipotent and pluripotent stem cells in a manner similar to that which generates diversity in hematopoietic cell populations. Identification and characterization of the stem cell and progenitor populations in the intestine has been limited by the absence of markers or culture systems to identify these cells. Regulation of the proliferative compartment may be accomplished through the combined integration of key peptide growth factors and constituents of the extracellular matrix. The relative contribution of the epithelial populations themselves and the contributions made by associated cell populations such as pericryptal fibroblasts remain unclear. Recent studies have suggested that the transforming growth factors-alpha and -beta, two structurally unrelated peptide growth factors, might serve to regulate the balanced proliferation and turnover of intestinal epithelial cells. The proproliferative effects of TGF-alpha may be counterbalanced by the proliferation-inhibiting TGF-beta. Recent studies have demonstrated close interregulation of these peptides, which act through autocrine and paracrine mechanisms in model intestinal epithelial cell lines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8447399     DOI: 10.1152/ajpgi.1993.264.2.G179

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  44 in total

1.  Amphiregulin promotes intestinal epithelial regeneration: roles of intestinal subepithelial myofibroblasts.

Authors:  Jinyi Shao; Hongmiao Sheng
Journal:  Endocrinology       Date:  2010-06-09       Impact factor: 4.736

2.  A case of unexpected regeneration of small intestinal mucosal necrosis.

Authors:  Dong Wook Kim; Youn Joon Park
Journal:  Pediatr Surg Int       Date:  2012-01       Impact factor: 1.827

Review 3.  EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new?

Authors:  Shailender Singh Kanwar; Jyoti Nautiyal; Adhip P N Majumdar
Journal:  Curr Drug Targets       Date:  2010-06       Impact factor: 3.465

4.  Immuno-epithelial interactions: cytokine modulation of normal rabbit colonocyte function.

Authors:  A Vidrich; P A Anton; F Shanahan
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998 Nov-Dec       Impact factor: 2.416

Review 5.  Ontogeny, growth and development of the small intestine: Understanding pediatric gastroenterology.

Authors:  Laurie A Drozdowski; Tom Clandinin; Alan B R Thomson
Journal:  World J Gastroenterol       Date:  2010-02-21       Impact factor: 5.742

Review 6.  Adaptation of intestinal nutrient transport in health and disease. Part II.

Authors:  A B Thomson; G Wild
Journal:  Dig Dis Sci       Date:  1997-03       Impact factor: 3.199

7.  Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells.

Authors:  H Sheng; J Shao; C M Townsend; B M Evers
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 8.  Epithelial restitution and wound healing in inflammatory bowel disease.

Authors:  Andreas Sturm; Axel U Dignass
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

9.  Oral administration of rapamycin and cyclosporine differentially alter intestinal function in rabbits.

Authors:  V C Dias; K L Madsen; K E Mulder; M Keelan; R W Yatscoff; A B Thomson
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

Review 10.  The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis.

Authors:  Nikunj K Chokshi; Yigit S Guner; Catherine J Hunter; Jeffrey S Upperman; Anatoly Grishin; Henri R Ford
Journal:  Semin Perinatol       Date:  2008-04       Impact factor: 3.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.